4th Annual

mRNA Conference USA 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Ismail Hafez

Ismail Hafez

Ionis Pharmaceuticals Inc.

Close icon
Marieke Zhao

Marieke Zhao

Syner-G

Ismail Hafez

Ismail Hafez

Ionis Pharmaceuticals Inc.

Kok-Seong Lim

Kok-Seong Lim

Independent Consultant

GLOBAL FORUM FOR MRNA-BASED THERAPEUTICS AND DRUG DEVELOPMENT

Welcome to mRNA Conference USA 2026, where global pharmaceutical and biotech leaders join industry experts to explore breakthroughs in mRNA therapeutics for vaccines, personalized medicine, and beyond.

The event explores the role of mRNA technology in developing novel treatments, covering the full spectrum from R&D to clinical trials, large-scale manufacturing, and commercialization. It highlights advancements in RNA modification, therapeutic delivery systems, and vaccine development, and showcases the latest progress in mRNA, siRNA, and miRNA-based therapeutics.

Join us to explore next-generation mRNA therapeutics, gain valuable insights, and connect with peers to help shape the future of medicine.

key topics for

Future of mRNA-based therapeutics for infectious diseases and beyond

Explore the potential of mRNA therapeutics as a transformative new class of drugs.

Breakthrough research in mRNA, siRNA, and miRNA-based therapeutics

Gain insights into how advancements in mRNA, siRNA, and miRNA are shaping the future of therapeutic applications.

Challenges in scaling mRNA vaccines manufacturing for global distribution

Analyze advanced methods for the rapid development and large-scale distribution of vaccines in response to pandemics.

Latest advancements in mRNA formulation and delivery technologies

Discover the latest advancements in therapeutic mRNA delivery as they progress from the laboratory to patient treatment.

AI and ML-driven approaches to enhance mRNA therapeutic design

Learn how advanced AI and machine learning algorithms, combined with data analytics, are accelerating therapeutic design and revealing new insights.

Regulatory and compliance considerations in mRNA clinical development

Understand key regulatory and compliance considerations for the approval of mRNA therapeutics.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • PARTNERSHIPS

    3 Feb 2026

    BioNTech–CureVac Deal Marks a New Era for mRNA
  • PARTNERSHIPS

    20 Jan 2026

    GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races
  • INSIGHTS

    19 Jan 2026

    BMS–Orbital Deal Signals a Sharper Bet on In Vivo RNA
  • RESEARCH

    16 Jan 2026

    mRNA Developers Regroup After Trial Setbacks

AI Alliance Refines RNA Cancer Drug Discovery

Oncovita company logo linked to RNA oncology drug development

PARTNERSHIPS

13 Jan 2026

Oncovita teams with Infinitusbio.AI to use digital cell modeling to sharpen early decisions in RNA oncology research

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Kok-Seong Lim

Independent Consultant

Craig Martin

University of Massachusetts

Pintu Kanjilal

Strand Therapeutics

Show more Speakers

Past Attendees

Sanofi

28 Capital

Mayo Clinic

Arcturus Therapeutics

Crafton Biotechnology

Tessera Therapeutics

TriLink BioTechnologies

Standard BioTools

University of Michigan

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
HPNE_Endorsed_HZ_RGBMN_Logo_kompakt_1cRothwell FiggBendBioscience Black Logo
arrow icon

related events in the series